(Q43339110)

19 November 2017

Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats (English)

1 reference

19 November 2017

1 reference

Zhang Y

1

1 reference

19 November 2017

Raap DK

2

1 reference

19 November 2017

Garcia F

3

1 reference

19 November 2017

Serres F

4

1 reference

19 November 2017

Ma Q

5

1 reference

19 November 2017

Battaglia G

6

1 reference

19 November 2017

Van de Kar LD

7

1 reference

19 November 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

19 November 2017

1 reference

19 November 2017

855

1 reference

19 November 2017

58-66

1 reference

19 November 2017

1

1 reference

Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas.

19 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

5-HT and antidepressants: new views from microdialysis studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Serotonin, anxiety, and stress hormones. Focus on 5-HT receptor subtypes, species and gender differences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Increased defaecation caused by 5-HT4 receptor activation in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Forebrain pathways and their behavioural interactions with neuroendocrine and cardiovascular function in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Role for serotonin3 receptors in the control of adrenocorticotropic hormone release from rat pituitary cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

5-HT1A receptor agonists: recent developments and controversial issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

5-HT and mechanisms of defence. Author's response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

The new generation of serotonergic anxiolytics: possible clinical roles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Serotonin-1A anxiolytics: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Role of serotonin in the amygdala in hypothalamo-pituitary-adrenocortical responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Posterior hypothalamic deafferentation or 5,7-dihydroxytryptamine inhibit corticotropin-releasing hormone, ACTH and corticosterone responses following photic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Sex steroid control of mood, mental state and memory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

The involvement of noradrenergic ascending pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of stressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Dual role of 5-HT in defense and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

The 5-HT1A receptor is not involved in emotional stress-induced rises in stress hormones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

5-Hydroxytryptamine pathways in anxiety and its treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Serotonergic activation reduces defensive freezing in the conditioned fear paradigm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Serotonergic involvement in stress-induced ACTH release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Interactions of histaminergic and serotonergic neurons in the hypothalamic regulation of prolactin and ACTH secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Effect of serotonin 5-HT1, 5-HT2, and 5-HT3 receptor antagonists on the prolactin response to restraint and ether stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Serotonin and anxiety revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

The treatment of comorbid premature ejaculation and panic disorder with fluoxetine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Neurochemical changes associated with the action of acute administration of diazepam in reversing the behavioral paradigm conditioned emotional response (CER)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Fluoxetine gradually increases [125I]DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq- and G11-proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Paroxetine in social phobia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

The amygdala and fear conditioning: has the nut been cracked?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Effects of repeated doses of azapirones on rat brain 5-HT1A receptors and plasma corticosterone levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Increased colonic motility during exposure to a stressful situation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Gastrointestinal motility stimulating drugs and 5-HT receptors on myenteric neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Role of noradrenergic projections to the bed nucleus of the stria terminalis in neuroendocrine and behavioral responses to fear-related stimuli in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Can the effects of antidepressants be observed in the first two weeks of treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Rapid depletion of plasma tryptophan: a review of studies and experimental methodology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Neuronal cell bodies in the hypothalamic paraventricular nucleus mediate stress-induced renin and corticosterone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Stress-induced renin and corticosterone secretion is mediated by catecholaminergic nerve terminals in the hypothalamic paraventricular nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Serotonergic anxiolytics and treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Differential inhibition of stress-induced adrenocortical responses by 5-HT1A agonists and by 5-HT2 and 5-HT3 antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Effects of the serotonin1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin on neurochemical responses to stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Delayed onset of action of antidepressant drugs? Survey of recent results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress responses in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Chronic fluoxetine or desmethylimipramine treatment alters 5-HT2 receptor mediated c-fos gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Effects of acute and chronic fluoxetine treatment of CRH-induced anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Forebrain pathways mediating stress-induced hormone secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Agonist-induced down-regulation of human 5-HT1A and 5-HT2 receptors in Swiss 3T3 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

The effect of low brain serotonin on mood and aggression in humans. Influence of baseline mood and genetic factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902289-1

10.1016/S0006-8993(99)02289-1

7 January 2021

Identifiers

DOI

1 reference

19 November 2017

1 reference